NK cell activation in cancer patients following BioBran intake

NK cell activity was compared before and after 6 months of BioBran intake in 25 cancer patients with progressive disease, who received chemotherapy, surgery, and/or hormone therapy. Although a large difference in the baseline activity was observed between patients, all patients demonstrated an increase in NK cell activity after BioBran intake.

Ghoneum M. and G. Namatalla, 87th Annual Meeting of the American Association for Cancer Research, 1996